Literature DB >> 3285574

Rift Valley fever virus M segment: cell-free transcription and translation of virus-complementary RNA.

J A Suzich1, M S Collett.   

Abstract

A cell-free system has been used to study gene expression of the M segment RNA of the Phlebovirus Rift Valley fever virus (RVFV). RVFV sequence-containing plasmids were used to synthesize M segment mRNA-like transcripts. These transcripts were then translated in vitro in the absence or presence of microsomal membranes. Cell-free translation of a transcript which closely resembled authentic M segment mRNA (RNA-7) yielded a primary translation product of 133 kilodaltons (kDa), the size expected of a polypeptide encompassing the entire open reading frame (ORF) of the M segment. When translations were conducted in the presence of microsomal membranes, this primary protein was cotranslationally processed to yield the two viral glycoproteins, G1 and G2, as well as proteins of 78, 21, and 14 kDa. With one exception, these in vitro processed polypeptides comigrated with M segment-encoded proteins found in RVFV-infected cell lysates. A polypeptide corresponding to the in vitro 21-kDa protein was not detected in vivo. To investigate translational initiation and processing of the protein products of the M segment, additional transcripts were generated in which varying portions of the amino-terminal "preglycoprotein" region of the M segment ORF were deleted. Translation results indicated that the 78- and 21-kDa proteins were initiated from the first methionine codon of the ORF, and the 14-kDa polypeptide began from the second in-phase ATG. These products and a major portion of the preglycoprotein region sequence were not required for the proper synthesis and processing of the viral glycoproteins in vitro. In light of these results, possible expression strategies used by this Phlebovirus M segment RNA are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285574     DOI: 10.1016/0042-6822(88)90562-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Oligomerization, transport, and Golgi retention of Punta Toro virus glycoproteins.

Authors:  S Y Chen; R W Compans
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

2.  Expression strategy of a phlebovirus: biogenesis of proteins from the Rift Valley fever virus M segment.

Authors:  J A Suzich; L T Kakach; M S Collett
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Maize stripe tenuivirus RNA2 transcripts in plant and insect hosts and analysis of pvc2, a protein similar to the Phlebovirus virion membrane glycoproteins.

Authors:  E M Estabrook; K Suyenaga; J H Tsai; B W Falk
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

4.  NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis.

Authors:  Sungyong Won; Tetsuro Ikegami; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

5.  Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class II viral fusion protein (beta-penetrenes).

Authors:  Courtney E Garry; Robert F Garry
Journal:  Theor Biol Med Model       Date:  2004-11-15       Impact factor: 2.432

6.  The Rift Valley fever accessory proteins NSm and P78/NSm-GN are distinct determinants of virus propagation in vertebrate and invertebrate hosts.

Authors:  Felix Kreher; Carole Tamietti; Céline Gommet; Laurent Guillemot; Myriam Ermonval; Anna-Bella Failloux; Jean-Jacques Panthier; Michèle Bouloy; Marie Flamand
Journal:  Emerg Microbes Infect       Date:  2014-10-01       Impact factor: 7.163

7.  Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression.

Authors:  Inaia Phoenix; Nandadeva Lokugamage; Shoko Nishiyama; Tetsuro Ikegami
Journal:  Viruses       Date:  2016-05-24       Impact factor: 5.048

8.  Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation.

Authors:  Tetsuro Ikegami; Krishna Narayanan; Sungyong Won; Wataru Kamitani; C J Peters; Shinji Makino
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

9.  Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins.

Authors:  Li Liu; Cristina C P Celma; Polly Roy
Journal:  Virol J       Date:  2008-07-18       Impact factor: 4.099

10.  N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN.

Authors:  Inaia Phoenix; Shoko Nishiyama; Nandadeva Lokugamage; Terence E Hill; Matthew B Huante; Olga A L Slack; Victor H Carpio; Alexander N Freiberg; Tetsuro Ikegami
Journal:  Viruses       Date:  2016-05-23       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.